Literature DB >> 3827862

Collagen defects in lethal perinatal osteogenesis imperfecta.

J F Bateman, D Chan, T Mascara, J G Rogers, W G Cole.   

Abstract

Quantitative and qualitative abnormalities of collagen were observed in tissues and fibroblast cultures from 17 consecutive cases of lethal perinatal osteogenesis imperfecta (OI). The content of type I collagen was reduced in OI dermis and bone and the content of type III collagen was also reduced in the dermis. Normal bone contained 99.3% type I and 0.7% type V collagen whereas OI bone contained a lower proportion of type I, a greater proportion of type V and a significant amount of type III collagen. The type III and V collagens appeared to be structurally normal. In contrast, abnormal type I collagen chains, which migrated slowly on electrophoresis, were observed in all babies with OI. Cultured fibroblasts from five babies produced a mixture of normal and abnormal type I collagens; the abnormal collagen was not secreted in two cases and was slowly secreted in the others. Fibroblasts from 12 babies produced only abnormal type I collagens and they were also secreted slowly. The slower electrophoretic migration of the abnormal chains was due to enzymic overmodification of the lysine residues. The distribution of the cyanogen bromide peptides containing the overmodified residues was used to localize the underlying structural abnormalities to three regions of the type I procollagen chains. These regions included the carboxy-propeptide of the pro alpha 1(I)-chain, the helical alpha 1(I) CB7 peptide and the helical alpha 1(I) CB8 and CB3 peptides. In one baby a basic charge mutation was observed in the alpha 1(I) CB7 peptide and in another baby a basic charge mutation was observed in the alpha 1(I) CB8 peptide. The primary defects in lethal perinatal OI appear to reside in the type I collagen chains. Type III and V collagens did not appear to compensate for the deficiency of type I collagen in the tissues.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3827862      PMCID: PMC1147476          DOI: 10.1042/bj2400699

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  The separation and characterization of the alpha- and beta-components of calf skin collagen.

Authors:  K A PIEZ; E WEISS; M S LEWIS
Journal:  J Biol Chem       Date:  1960-07       Impact factor: 5.157

2.  The cyanogen bromide peptides of bovine soluble and insoluble collagens. I. Characterization of peptides from soluble type I collagen by sodium dodecylsulphate polyacrylamide gel electrophoresis.

Authors:  P G Scott; A Veis
Journal:  Connect Tissue Res       Date:  1976       Impact factor: 3.417

3.  Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta.

Authors:  J Bonadio; K A Holbrook; R E Gelinas; J Jacob; P H Byers
Journal:  J Biol Chem       Date:  1985-02-10       Impact factor: 5.157

4.  (Alpha1(3))3 human skin collagen. Release by pepsin digestion and preponderance in fetal life.

Authors:  E H Epstein
Journal:  J Biol Chem       Date:  1974-05-25       Impact factor: 5.157

5.  Chemical and immunological properties of reduced and alkylated polypeptide chains of bovine fibrinogen.

Authors:  R Gollwitzer; R Timpl; U Becker; H Furthmayr
Journal:  Eur J Biochem       Date:  1972-08-04

6.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

7.  Rapid fractionation of collagen chains and peptides by high-performance liquid chromatography.

Authors:  J F Bateman; T Mascara; D Chan; W G Cole
Journal:  Anal Biochem       Date:  1986-04       Impact factor: 3.365

8.  Fetal membrane collagens: identification of two new collagen alpha chains.

Authors:  R E Burgeson; F A El Adli; I I Kaitila; D W Hollister
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

9.  Diminished type I collagen synthesis and reduced alpha 1(I) collagen messenger RNA in cultured fibroblasts from patients with dominantly inherited (type I) osteogenesis imperfecta.

Authors:  D W Rowe; J R Shapiro; M Poirier; S Schlesinger
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

10.  On the significance of the extractable collagens.

Authors:  D S JACKSON; J P BENTLEY
Journal:  J Biophys Biochem Cytol       Date:  1960-02
View more
  35 in total

1.  Collagen metabolism in cultured osteoblasts from osteogenesis imperfecta patients.

Authors:  M Mörike; R E Brenner; G B Bushart; W M Teller; U Vetter
Journal:  Biochem J       Date:  1992-08-15       Impact factor: 3.857

2.  The clinical features of osteogenesis imperfecta resulting from a non-functional carboxy terminal pro alpha 1(I) propeptide of type I procollagen and a severe deficiency of normal type I collagen in tissues.

Authors:  W G Cole; P E Campbell; J G Rogers; J F Bateman
Journal:  J Med Genet       Date:  1990-09       Impact factor: 6.318

3.  Increased expression of the gene for the pro alpha 1(IV) chain of basement-membrane procollagen in cultured skin fibroblasts from two variants of osteogenesis imperfecta.

Authors:  T Pihlajaniemi; J McKeon; S Gay; R Gay; W J de Wet; J C Myers; D J Prockop
Journal:  Biochem J       Date:  1989-01-15       Impact factor: 3.857

4.  Pulse-chase analysis of procollagen biosynthesis by azidohomoalanine labeling.

Authors:  Lynn S Mirigian; Elena Makareeva; Sergey Leikin
Journal:  Connect Tissue Res       Date:  2014-09-22       Impact factor: 3.417

5.  Disruption of one intra-chain disulphide bond in the carboxyl-terminal propeptide of the proalpha1(I) chain of type I procollagen permits slow assembly and secretion of overmodified, but stable procollagen trimers and results in mild osteogenesis imperfecta.

Authors:  J M Pace; C D Kuslich; M C Willing; P H Byers
Journal:  J Med Genet       Date:  2001-07       Impact factor: 6.318

6.  Metabolic studies on connective tissue collagens in bone and tendon of adjuvant arthritic rat.

Authors:  G K Reddy; S C Dhar
Journal:  Calcif Tissue Int       Date:  1992-04       Impact factor: 4.333

7.  Disrupted growth plates and progressive deformities in osteogenesis imperfecta as a result of the substitution of glycine 585 by valine in the alpha 2 (I) chain of type I collagen.

Authors:  W G Cole; D Chan; C W Chow; J G Rogers; J F Bateman
Journal:  J Med Genet       Date:  1996-11       Impact factor: 6.318

Review 8.  Perinatal lethal osteogenesis imperfecta.

Authors:  W G Cole; R Dalgleish
Journal:  J Med Genet       Date:  1995-04       Impact factor: 6.318

9.  Myocardial infarction resulting from coronary artery dissection in an adolescent with Ehlers-Danlos syndrome type IV due to a type III collagen mutation.

Authors:  L C Adès; R D Waltham; A A Chiodo; J F Bateman
Journal:  Br Heart J       Date:  1995-08

10.  A single base mutation in the gene for type III collagen (COL3A1) converts glycine 847 to glutamic acid in a family with Ehlers-Danlos syndrome type IV. An unaffected family member is mosaic for the mutation.

Authors:  A J Richards; P N Ward; P Narcisi; A C Nicholls; J C Lloyd; F M Pope
Journal:  Hum Genet       Date:  1992-06       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.